Todos Medical Revenue and Competitors

Todos Medical Ltd. (OTCQB: TOMDF) an Israeli company headquartered in Rehovot, is a cancer in-vitro-diagnostic (“IVD”) company developing a series of blood tests for the early detection of a variety of cancers. Our new cancer tests will add a layer to currently available cancer screening and diagnostics. Our goal is to help save lives through early detection while being minimally invasive to the patient. The company has developed two cancer screening tests based on TBIA (Todos Biochemical Infrared Analyses), a method for cancer screening using peripheral blood analysis. The TBIA screening method is based on the cancer's influence on the immune system which triggers biochemical changes in peripheral blood mononuclear cells (“PBMC”) and plasma. This proprietary and patented method incorporates biochemistry, physics and signal processing. The company's two cancer screening tests for breast cancer, TM-B1 and TM-B2, are CE marked in the EU. The company is also developing our proprietary TM-C1 cancer test targeting the detection of colorectal cancers at an early stage.